Table of Contents
(Source: HIV Medicine)
Source: HIV Medicine - August 1, 2017 Category: Infectious Diseases Tags: Issue Information Source Type: research
Editorial Board
(Source: HIV Medicine)
Source: HIV Medicine - August 1, 2017 Category: Infectious Diseases Tags: Issue Information Source Type: research
HIV incidence in the Estonian population in 2013 determined using the HIV ‐1 limiting antigen avidity assay
ConclusionsThese high HIV incidence estimates in Estonia call for urgent action of renewed targeted public health promotion and HIV testing campaigns. (Source: HIV Medicine)
Source: HIV Medicine - August 1, 2017 Category: Infectious Diseases Authors: P Soodla, R Simmons, K Huik, M Pauskar, E ‐L Jõgeda, H Rajasaar, E Kallaste, M Maimets, R Avi, G Murphy, K Porter, I Lutsar, Tags: Original Research Source Type: research
Discordant rapid HIV tests: lessons from a low ‐resource community
ConclusionsWhen the sample occurrence of discordance between the first and second tests is below 5%, discordant rapid tests in an adult with sexual risk behaviour should trigger strong suspicion of early HIV infection in low HIV prevalence populations. (Source: HIV Medicine)
Source: HIV Medicine - July 31, 2017 Category: Infectious Diseases Authors: AA Adetunji, MA Kuti, RA Audu, SA Muyibi, M Imhansoloeva, OA Mosuro, EA Solanke, OM Akpa, AE Irabor, MMA Ladipo, B Berzins, K Robertson, A Ogunniyi, IF Adewole, BO Taiwo Tags: Short Communication Source Type: research
Severe depression as a neuropsychiatric side effect induced by dolutegravir
(Source: HIV Medicine)
Source: HIV Medicine - July 26, 2017 Category: Infectious Diseases Authors: H Scheper, N Holten, JGFM Hovens, MGJ Boer Tags: Letter to the Editor Source Type: research
Severe depression as a neuropsychiatric side effect induced by dolutegravir
HIV Medicine,Volume 19, Issue 4, Page e58-e59, April 2018. (Source: HIV Medicine)
Source: HIV Medicine - July 26, 2017 Category: Infectious Diseases Source Type: research
---
HIV Medicine, Ahead of Print. (Source: HIV Medicine)
Source: HIV Medicine - July 26, 2017 Category: Infectious Diseases Source Type: research
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
ConclusionsImmunovirological response to cART in Western Europe varies by GO and sex of patients. ART benefits are not equal for all, underlining the point that efforts need to prioritize those most in need. (Source: HIV Medicine)
Source: HIV Medicine - July 25, 2017 Category: Infectious Diseases Tags: Original Research Source Type: research
Nucleoside reverse transcriptase inhibitor ‐reducing strategies in HIV treatment: assessing the evidence
Antiretroviral (ARV) therapy, comprising a backbone of two nucleos(t)ide reverse transcriptase inhibitors (NRTIs) plus another ARV, is the recognized standard of care (SOC), which has helped extend life expectancy in people living with HIV. In a quest to reduce lifelong drug exposure and minimize or avoid the toxicity of NRTIs, “NRTI‐reducing” regimens have been investigated. This descriptive review assessing the results of NRTI‐reducing strategies from the largest randomized trials focuses on virological efficacy, resistance, regimen safety (in terms of bone mineral density, renal function, lipids and central nerv...
Source: HIV Medicine - July 24, 2017 Category: Infectious Diseases Authors: C Orkin, JM Llibre, S Gallien, A Antinori, GMN Behrens, A Carr Tags: Reviews in Antiretroviral Research Source Type: research
Correlates of frailty phenotype and frailty index and their associations with clinical outcomes
ConclusionsThe frailty phenotype and the FI demonstrated similar characteristics in patients at a tertiary‐level HIV clinic. The FI had a stronger association with age, nadir CD4 count, comorbidities, falls, and disability. Integrating frailty assessments in clinical practice will be crucial for the development of interventions in age‐related conditions, including disability and falls, in older persons living with HIV. (Source: HIV Medicine)
Source: HIV Medicine - July 24, 2017 Category: Infectious Diseases Authors: G Guaraldi, A Malagoli, O Theou, TD Brothers, LMK Wallace, R Torelli, C Mussini, S Sartini, SA Kirkland, K Rockwood Tags: Original Research Source Type: research
The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial
ConclusionsAlthough safe, IVIG in AHI did not impact total HIV DNA, immune function or microbial translocation in peripheral blood or gut tissue. (Source: HIV Medicine)
Source: HIV Medicine - July 18, 2017 Category: Infectious Diseases Authors: J Tiraboschi, S Ray, K Patel, A Teague, M Pace, P Phalora, N Robinson, E Hopkins, J Meyerowitz, Y Wang, J Cason, S Kaye, J Sanderson, P Klenerman, S Fidler, J Frater, J Fox Tags: Short communication Source Type: research
Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study
ConclusionsMVC as a switch for a PI/r is safe and effective at maintaining virological suppression while having significant lipid benefits over 96 weeks. (Source: HIV Medicine)
Source: HIV Medicine - July 13, 2017 Category: Infectious Diseases Authors: SL Pett, J Amin, A Horban, J Andrade ‐Villanueva, M Losso, N Porteiro, JS Madero, W Belloso, E Tu, D Silk, A Kelleher, R Harrigan, A Clark, W Sugiura, M Wolff, J Gill, J Gatell, A Clarke, K Ruxrungtham, T Prazuck, R Kaiser, I Woolley, J Alberto Arnaiz, Tags: Short Communication Source Type: research
Table of Contents
(Source: HIV Medicine)
Source: HIV Medicine - July 13, 2017 Category: Infectious Diseases Tags: Issue Information Source Type: research
Editorial Board
(Source: HIV Medicine)
Source: HIV Medicine - July 13, 2017 Category: Infectious Diseases Tags: Issue Information Source Type: research
Insurance status and mortality among patients with AIDS
ConclusionsIn persons with AIDS, compared with those with private insurance, those with public insurance had increased mortality, possibly as a result of a greater burden of noninfectious, age‐related diseases. (Source: HIV Medicine)
Source: HIV Medicine - July 1, 2017 Category: Infectious Diseases Authors: AW Jabs, DA Jabs, ML Van Natta, FJ Palella, CL Meinert, Tags: Original Research Source Type: research
